Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide 1”

624 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 624 results

Not applicableStudy completedNCT02235584
What this trial is testing

Insulinotropic Effect of GLP-1 and GIP After Dexamethasone

Who this might be right for
Type 2 Diabetes
Hvidovre University Hospital 19
Large-scale testing (Phase 3)Study completedNCT03216226
What this trial is testing

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Who this might be right for
HypoglycemiaDiabetes Mellitus, Type 1
Zealand Pharma 112
Not applicableStudy completedNCT04926415
What this trial is testing

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Obesity and Insulin Resistance

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Burrell College of Osteopathic Medicine 30
Not applicableStudy completedNCT01656057
What this trial is testing

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

Who this might be right for
To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion
Filip Krag Knop 10
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Large-scale testing (Phase 3)Study completedNCT03421379
What this trial is testing

Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Eli Lilly and Company 75
Not applicableLooking for participantsNCT06685146
What this trial is testing

The Glucose-Independent Effects of Exogenous Glucagon on Insulin Secretion and Cognitive Function in Healthy Subjects

Who this might be right for
Glucose MetabolismInsulin Secretion
Nicolai Jacob Wewer Albrechtsen 10
Not applicableStudy completedNCT00716170
What this trial is testing

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

Who this might be right for
Type 2 Diabetes Mellitus
Herlev Hospital 10
Not applicableEnded earlyNCT02701257
What this trial is testing

The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas

Who this might be right for
Diabetes Mellitus Type 1
Massachusetts General Hospital 20
Not applicableStudy completedNCT00811317
What this trial is testing

Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Boston University Charles River Campus 11
Early research (Phase 1)Study completedNCT00468091
What this trial is testing

Effects of Exendin(9-39) on Gastroduodenal Motility

Who this might be right for
Digestive PhysiologyGastrointestinal MotilityGastrointestinal Hormones+2 more
Ludwig-Maximilians - University of Munich 10
Post-approval studies (Phase 4)UnknownNCT05606471
What this trial is testing

Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets

Who this might be right for
Type 2 Diabetes Mellitus in Obese
University of Nottingham 45
Large-scale testing (Phase 3)Study completedNCT01997411
What this trial is testing

Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT07073053
What this trial is testing

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

Who this might be right for
Glucagon-Like Peptide-1 Receptor AgonistsType 2 DiabetesCoronary Arterial Disease (CAD)
Taipei Veterans General Hospital, Taiwan 60
Large-scale testing (Phase 3)Study completedNCT03422666
What this trial is testing

Plasma Lipoprotein Response to Glucagon-like Peptide-2

Who this might be right for
Hyperlipidemias
University Health Network, Toronto 10
Large-scale testing (Phase 3)Temporarily pausedNCT03508739
What this trial is testing

Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

Who this might be right for
Diabetes Mellitus, Type 2Pre-diabeticHypertension+1 more
University of Pennsylvania 25
Post-approval studies (Phase 4)Study completedNCT00950677
What this trial is testing

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Baylor College of Medicine 16
Post-approval studies (Phase 4)Not Yet RecruitingNCT07111494
What this trial is testing

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

Who this might be right for
Psoriatic Arthritis (PsA)
Medical College of Wisconsin 22
Testing effectiveness (Phase 2)Study completedNCT02057172
What this trial is testing

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 254
Load More Results